BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 29716729)

  • 21. Extent of lymph node resection does not increase perioperative morbidity and mortality after surgery for stage I lung cancer in the elderly.
    Shapiro M; Mhango G; Kates M; Weiser TS; Chin C; Swanson SJ; Wisnivesky JP
    Eur J Surg Oncol; 2012 Jun; 38(6):516-22. PubMed ID: 22244908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary Resection for Second Lung Cancer After Pneumonectomy: A Population-Based Study.
    Ayub A; Rehmani SS; Al-Ayoubi AM; Raad W; Flores RM; Bhora FY
    Ann Thorac Surg; 2017 Oct; 104(4):1131-1137. PubMed ID: 28709663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sublobar resection for lung adenocarcinoma meeting node-negative criteria on preoperative imaging.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    Ann Thorac Surg; 2014 May; 97(5):1701-7. PubMed ID: 24679941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative complications and prognosis after lobar resection versus sublobar resection in elderly patients with clinical Stage I non-small-cell lung cancer.
    Tsutani Y; Tsubokawa N; Ito M; Misumi K; Hanaki H; Miyata Y; Okada M
    Eur J Cardiothorac Surg; 2018 Feb; 53(2):366-371. PubMed ID: 28958068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
    Tsutani Y; Mimura T; Kai Y; Ito M; Misumi K; Miyata Y; Okada M
    J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1089-1096.e1. PubMed ID: 28483268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sublobar resection versus definitive radiation in patients with stage IA non-small cell lung cancer.
    Fernandez FG; Crabtree TD; Liu J; Meyers BF
    Ann Thorac Surg; 2012 Aug; 94(2):354-60; discussion 360-1. PubMed ID: 22429673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The extent of mediastinal lymph node dissection correlates with survival of small cell lung cancer patients after resection: a propensity score-matched cohort study analysis.
    Cao J; Xu J; Yu H; Qian P; Lv W; He T; Yuan P; Longo F; Bertolaccini L; Yasufuku K; Rucker AJ; Hu J
    Transl Lung Cancer Res; 2022 Jul; 11(7):1453-1467. PubMed ID: 35958338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sublobar resection is equivalent to lobectomy for T1a non-small cell lung cancer in the elderly: a Surveillance, Epidemiology, and End Results database analysis.
    Razi SS; John MM; Sainathan S; Stavropoulos C
    J Surg Res; 2016 Feb; 200(2):683-9. PubMed ID: 26490227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time trend of mediastinal lymph node dissection in stage IA non-small cell lung cancer patient who undergo lobectomy: a retrospective study of surveillance, epidemiology, and end results (SEER) database.
    Pan L; Mo R; Zhu L; Yu W; Lv W; Hu J
    J Cardiothorac Surg; 2020 Aug; 15(1):207. PubMed ID: 32738925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States.
    Speicher PJ; Gu L; Gulack BC; Wang X; D'Amico TA; Hartwig MG; Berry MF
    Clin Lung Cancer; 2016 Jan; 17(1):47-55. PubMed ID: 26602547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spread Through Air Spaces Is a Prognostic Factor in Sublobar Resection of Non-Small Cell Lung Cancer.
    Shiono S; Endo M; Suzuki K; Yarimizu K; Hayasaka K; Yanagawa N
    Ann Thorac Surg; 2018 Aug; 106(2):354-360. PubMed ID: 29625101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lobe-Specific Lymph Node Dissection for Clinical Early-Stage (cIA) Peripheral Non-small Cell Lung Cancer Patients: What and How?
    Deng HY; Zhou J; Wang RL; Jiang R; Zhu DX; Tang XJ; Zhou Q
    Ann Surg Oncol; 2020 Feb; 27(2):472-480. PubMed ID: 31617120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of the number of lymph nodes removed at lobectomy in stage IA non-small cell lung cancer.
    Ou SH; Zell JA
    J Thorac Oncol; 2008 Aug; 3(8):880-6. PubMed ID: 18670306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registry.
    Dziedzic R; Zurek W; Marjanski T; Rudzinski P; Orlowski TM; Sawicka W; Marczyk M; Polanska J; Rzyman W
    Eur J Cardiothorac Surg; 2017 Aug; 52(2):363-369. PubMed ID: 28402455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical Choice for Clinical Stage IA Non-Small Cell Lung Cancer: View From Regional Lymph Node Metastasis.
    Deng HY; Zhou J; Wang RL; Jiang R; Qiu XM; Zhu DX; Tang XJ; Zhou Q
    Ann Thorac Surg; 2020 Apr; 109(4):1079-1085. PubMed ID: 31846634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer].
    Su XD; Wang X; Rong TH; Long H; Fu JH; Lin P; Zhang LJ; Wang SY; Wen ZS; Ma GW
    Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1543-5. PubMed ID: 18282391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Number of mediastinal lymph nodes in non-small cell lung cancer: a Gaussian curve, not a prognostic factor.
    Riquet M; Legras A; Mordant P; Rivera C; Arame A; Gibault L; Foucault C; Dujon A; Le Pimpec Barthes F
    Ann Thorac Surg; 2014 Jul; 98(1):224-31. PubMed ID: 24820386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected.
    Ren Y; Dai C; Shen J; Liu Y; Xie D; Zheng H; He J; Liang W; Jiang G; Fei K; Yang P; He J; Chen C
    Oncotarget; 2016 May; 7(18):26856-65. PubMed ID: 27057627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.